CClinicalTrials.gg
CompletedNCT06742398Updated Jul 24, 2025

Carbohydrates and Running Performance

An interventional study of Carbohydrate Dissolvable Strip and Carbohydrate Mouth Rinse in Nutrition, Healthy, sponsored by University of Georgia. Completed at 1 site in United States. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-07-24.

Sponsored by University of Georgia · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Feb 2024, registered Dec 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Study summary

Carbohydrates serve as the body's primary energy source during intense exercise, and consuming carbohydrates during exercise has been shown to improve exercise performance. Previous research has shown that the presence of carbohydrates in the mouth activates sweet taste receptors on the tongue, which signal the brain to increase neural activation in areas associated with motor functioning, sensory perception, and reward centers during exercise through this CPR. The primary objective of this intervention is to establish how carbohydrates delivered in different forms (MR versus dissolvable strip (DS)) affect running performance during a 12.8km running TT.

Read the detailed description

This trial will be a randomized, controlled crossover design in humans. There will be four study visits (see Figure 1 below). The first visit (Baseline Visit/V1) will entail signing informed consent documents, anthropometric measurements, familiarization with the MR and DS, and the exercise protocol. For the three testing visits (V2-V4), subjects will perform a 12.8 km running TT on a motorized treadmill, with the only difference between visits being the form of treatment. Either a carbohydrate MR solution (called CMR), water MR solution as a control (called WMR), or carbohydrate DS (called CDS) will be administered at each visit in a randomized order. Study visits will be separated by at least 5 days, and all visits will take place in the Human Nutrition Lab (HNL) at the University of Georgia in Athens.

Specific Aims:

  1. To examine the effect of carbohydrates delivered in different forms on running performance.
  2. To examine the effect of carbohydrates delivered in different forms on physiologic measures as well as perceived exertion.

Hypotheses:

  1. The investigators hypothesize that the carbohydrate-containing MR and DS will result in faster TT performance compared to a water MR (control).
  2. The Investigators hypothesize that the carbohydrate-containing DS and MR will elicit higher HR and blood lactate levels (indicating greater levels of intensity) compared to control without significantly increasing RPE during the running TT.
02

Conditions studied

  • Nutrition, Healthy
03

In context

Lead sponsor

University of Georgia is the lead sponsor of 72 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • 18-45 years old
  • Male or Female
  • Normal body mass index (BMI) between 18.0-24.9kg/m2
  • All subjects will be endurance-trained athletes who participate in training on a regular basis (≥4 sessions per week for at least 1 hour per session of aerobic/endurance exercise (such as running, cycling, or swimming)
  • Women will be tested only during the follicular phase of their menstrual cycle (days 2-9) to control for any fluctuation in hormones
  • Individuals aged 35 or older must pass the Physical Activity Readiness Questionnaire (PARQ2)

Exclusion criteria

Exclusion Criteria:

  • Anyone eating a low carbohydrate diet (such as The Zone™ Diet or Atkins™ Diet)
  • Changes in current exercise program
  • Chronic diseases (including but not limited to type II diabetes, hypertension, hypotension, hyperthyroidism, cardiovascular disease, and cancer)
  • Medications that could alter metabolic rate or hydration status
  • Supplement use other than fish oil or vitamin/mineral supplements
  • Nicotine use
  • Pregnancy or nursing
  • Donation of blood in the 20 days prior to testing
  • A failing result on the Physical Activity Readiness Questionnaire (PARQ2) for those aged 35 or older
  • Allergy to red food dye FD\&C Red No. 40
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
36 participants (actual)

Study arms

  • Active comparator
    Carbohydrate Mouth Rinse

    Subjects will be instructed to complete the 12.8 km time trial (TT) as quickly as possible. They will be able to adjust the speed on the treadmill throughout the TT but will have no knowledge of what speed they are actually running at. The researcher will monitor the progress of the TT, and the completion time will be recorded. The carbohydrate mouth rinse treatment will be given just before the start of the TT and every 12.5% of the TT, but not after the completion of the TT.

    Other: Carbohydrate Mouth Rinse

  • Sham comparator
    Water Mouth Rinse

    Subjects will be instructed to complete the 12.8 km time trial (TT) as quickly as possible. They will be able to adjust the speed on the treadmill throughout the TT but will have no knowledge of what speed they are actually running at. The researcher will monitor the progress of the TT, and the completion time will be recorded. The water mouth rinse treatment will be given just before the start of the TT and every 12.5% of the TT, but not after the completion of the TT.

    Other: Water Mouth Rinse

  • Experimental
    Carbohydrate Dissolvable Strip

    Subjects will be instructed to complete the 12.8 km time trial (TT) as quickly as possible. They will be able to adjust the speed on the treadmill throughout the TT but will have no knowledge of what speed they are actually running at. The researcher will monitor the progress of the TT, and the completion time will be recorded. The carbohydrate dissolvable strip treatment will be given just before the start of the TT and every 12.5% of the TT, but not after the completion of the TT.

    Other: Carbohydrate Dissolvable Strip

Interventions

  • OtherCarbohydrate Dissolvable Strip

    Participants are provided with a carbohydrate dissolvable strip for every 12.5% of the time trial that is completed (calculated based on the distance covered). The carbohydrate dissolvable strip (Innsol Health Corp.) is primarily composed of sucrose and glucose; however, the full ingredient list includes pullulan, mannitol, menthol, hydroxyl propyl methyl cellulose, eucalyptol, polysorbate 80, glyceryl oleate, purified water.

  • OtherCarbohydrate Mouth Rinse

    Participants are provided with a carbohydrate mouth rinse for every 12.5% of the time trial that is completed (calculated based on the distance covered). The sucrose solution will consist of 64g of sucrose dissolved in 1000 mL of water, with a bolus of 25 mL being used for each mouth rinse. Each mouth rinse solution will have 2mL of red food dye FD\&C Red No. 40 to ensure the same sensory response through appearance.

  • OtherWater Mouth Rinse

    Participants are provided with a water mouth rinse for every 12.5% of the time trial that is completed (calculated based on the distance covered). The water solution will consist of 1000 mL of water, with a bolus of 25 mL being used for each mouth rinse. Each mouth rinse solution will have 2mL of red food dye FD\&C Red No. 40 to ensure the same sensory response through appearance.

06

What researchers measure

Primary outcomes

  1. Completion Times

    Measured by the time it takes from the beginning of the time trial (0.0 km) to finish the 12.8 km distance (minutes and seconds).

    Time frame: Baseline/start time to approximately 1.5 hours

  2. Percent Change in Completion Time from Control

    Measured by subtracting the completion time of the experimental and active comparator treatments from the control/sham comparator and dividing by the control/sham comparator, then multiplying by 100 to convert to a percentage (percent change in completion time from control).

    Time frame: Baseline/start time to approximately 1.5 hours

  3. Mile Pace Splits During the Time Trial

    Measured by the time it takes to complete each individual 12.5% increment of the total 12.8 km time trial (minutes and seconds).

    Time frame: Baseline/start time to approximately 1.5 hours

  4. Blood Lactate Levels

    The blood lactate concentration immediately before beginning and after completion of the time trial at visits 2-4 (mmol/L).

    Time frame: Baseline to approximately 1.5 hours

  5. Ratings of Perceived Exertion

    The Borg's Rating of Perceived Exertion scale will be used to measure self-reported perceived exertion (RPE) ratings. The sale minimum is 6, and the maximum is 20. Higher scores indicate higher feelings of exertion.

    Time frame: Baseline/start time to approximately 1.5 hours

  6. Maximum Heart Rate

    A continuous heart rate monitor (Polar H9 Heart Rate Sensor) will measure maximum heart rate (beats per minute).

    Time frame: Baseline/start time to approximately 1.5 hours

  7. Change in Time Trial Heart Rate Values

    A continuous heart rate monitor (Polar H9 Heart Rate Sensor) will be used to measure heart rate throughout the time trial (beats per minute).

    Time frame: Change from baseline/start time to approximately 1.5 hours

  8. Percent Change in Blood Lactate Pre-to-Post Time Trial

    Measured by subtracting post-blood lactate from pre-blood lactate and dividing by pre-blood lactate, then multiplying by 100 to convert to a percentage (percent change in lactate).

    Time frame: Percent change from baseline/start time to approximately 1.5 hours

Secondary outcomes

  1. Body Weight Pre-to-Post Time Trial

    Body weight (kg)

    Time frame: Baseline/start time to approximately 1.5 hours

  2. Acute Dietary Intake

    One-day food logs will be used to record all foods and beverages consumed the day before testing days.

    Time frame: Day before visit 2, Day before visit 3, Day before visit 4

  3. Subjective Sensory Feelings by Treatment

    Subjective feelings related to the sweetness, saltiness, sourness, bitterness, savories, and pleasantness of intervention food are measured by visual analog scales (mm) and generalized labeled magnitude scales (mm). Both scales are measured from 0-100 mm. Higher ratings indicate higher sensory scores.

    Time frame: At the end of each testing visit (days 1-3)

Other outcomes

  1. Five-Point Just-About-Right Scale

    The Five-Point Just-About-Right Scale will be used to measure the appropriateness of each treatment according to consumer perception. The scale is measured from 1 to 5. Higher ratings indicate strong perceptions of the treatment.

    Time frame: At the end of each testing visit (days 1-3)

  2. Consumer Product Questionnaire

    A Consumer Product Questionnaire will assess various consumer experiences and perceptions regarding the dissolvable strip and Mouth rinse treatments. This questionnaire contains "yes or no" questions regarding nutrition supplementation and asks about consumer experiences if any past supplements have been used.

    Time frame: At the end of the final testing visit (day 3 of intervention)

  3. Net Promotor Score Rating

    A Net Promoter Score Questionnaire will be used to measure satisfaction by asking how likely it is that consumers would recommend the dissolvable strip product to a friend or colleague. The scale used goes from 1 to 10; the higher the score indicates an increased likeliness of recommending the product to a friend or colleague.

    Time frame: At the end of the testing visit in which the participants received the dissolvable strip (day 1, 2, or 3)

  4. New Product Questionnaire Rating

    A New Product Questionnaire will be used to measure various aspects such as market needs, product features, customer preferences, usage patterns, competitor analyses, pricing, purchase intent, and improvement suggestions to gather insights and feedback about the dissolvable strip product. The scale used goes from 1 to 5, and the greater the number, the worse the feeling about the product.

    Time frame: At the end of the testing visit in which the participants received the dissolvable strip (day 1, 2, or 3)

07

Study locations

1 site
  • University of Georgia
    Athens, Georgia 30602, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06742398
Lead sponsor
University of Georgia
Responsible party
Jamie Cooper, PhD (Professor and Department Head, University of Georgia) — Principal investigator
First posted
Dec 19, 2024
Start date
Feb 16, 2024
Primary completion
Jun 1, 2025
Completion
Jun 1, 2025
Last update
Jul 24, 2025

Study contacts

Jamie A Cooper, Ph.D.
principal investigator · University of Georgia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion